Technical Analysis for VVUS - VIVUS, Inc.

Grade Last Price % Change Price Change
grade C 4.2 -3.89% -0.17
VVUS closed down 3.89 percent on Friday, January 18, 2019, on 1.58 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical VVUS trend table...

Date Alert Name Type % Chg
Jan 18 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Jan 18 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Jan 18 Calm After Storm Range Contraction 0.00%
Jan 18 Upper Bollinger Band Walk Strength 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 17 Upper Bollinger Band Walk Strength -3.89%
Jan 17 Inside Day Range Contraction -3.89%
Jan 17 Wide Bands Range Expansion -3.89%
Jan 17 Overbought Stochastic Strength -3.89%
Jan 17 Upper Bollinger Band Touch Strength -3.89%

Older signals for VVUS ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
VIVUS, Inc., a biopharmaceutical company, engages in developing and commercializing therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health. The company offers Qsymia, a drug for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index of 30 or greater, or 27 or greater in the presence of at least one weight-related comorbidity, such as hypertension, type 2 diabetes mellitus, or high cholesterol; and STENDRA for the treatment of erectile dysfunction. It also completed Phase II clinical studies of Qsymia for the treatment of obstructive sleep apnea; and Qsymia for the treatment of type 2 diabetes. The company has an agreement with Mitsubishi Tanabe Pharma Corporation for the development and commercialization of avanafil, a PDE5 inhibitor compound for the oral and local treatment of male and female sexual dysfunction. VIVUS, Inc. was founded in 1991 and is headquartered in Mountain View, California.
Is VVUS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.88
52 Week Low 2.15
Average Volume 190,725
200-Day Moving Average 5.152
50-Day Moving Average 3.0754
20-Day Moving Average 3.0695
10-Day Moving Average 3.68
Average True Range 0.4076
ADX 30.77
+DI 40.1102
-DI 15.1624
Chandelier Exit (Long, 3 ATRs ) 4.0472
Chandelier Exit (Short, 3 ATRs ) 3.3728
Upper Bollinger Band 4.7386
Lower Bollinger Band 1.4004
Percent B (%b) 0.84
BandWidth 108.753869
MACD Line 0.3845
MACD Signal Line 0.1643
MACD Histogram 0.2202
Fundamentals Value
Market Cap 444.43 Million
Num Shares 106 Million
EPS 0.31
Price-to-Earnings (P/E) Ratio 13.55
Price-to-Sales 0.55
Price-to-Book 13.45
PEG Ratio -2.24
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.94
Resistance 3 (R3) 4.94 4.70 4.81
Resistance 2 (R2) 4.70 4.51 4.70 4.77
Resistance 1 (R1) 4.45 4.40 4.33 4.45 4.73
Pivot Point 4.21 4.21 4.15 4.21 4.21
Support 1 (S1) 3.96 4.02 3.84 3.96 3.67
Support 2 (S2) 3.72 3.91 3.72 3.63
Support 3 (S3) 3.47 3.72 3.59
Support 4 (S4) 3.47